Dr. Rafael Esteban Mur, researcher of the Liver Diseases group at Vall d’Hebron Institute of Research (VHIR) and head of the Hepatology Service at Vall d’Hebron University Hospital, returned from the "http://www2.kenes.com/liver-congress/pages/home.aspx" International Liver Congress held in Amsterdam (Netherlands) with a hopeful message: “In the coming years nearly 95% of patients with Hepatitis C will be cured”.The advances in oral treatments against this disease will provide in the near future safer drugs which will neutralize the virus without causing so many side effects as the current therapies with interferon. Dr. Esteban Mur, who participated in several presentations during the congress celebrated from the 24th to the 28th of April, explained which are the new drugs to treat Hepatitis C, in an interview published at Europa Press and EFE.